BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

2 hedge funds and large institutions have $11.1M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
2
Holders Change
-5
Holders Change %
-71.43%
% of All Funds
0.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
LIP
1
Liontrust Investment Partners
United Kingdom
$4.91M
2
BC
2
Birchview Capital
Vermont
$0
3
BTI
3
Blue Trust Inc
Georgia
$0
4
FIA
4
FNY Investment Advisers
New York
$0
5
IA
5
IFP Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
KCM
1
Knoll Capital Management
Florida
$6.15M 450,422 – –
LIP
2
Liontrust Investment Partners
United Kingdom
$4.91M 112,559 -22,100 -16%
BC
3
Birchview Capital
Vermont
– – -7,365 Closed
FIA
4
FNY Investment Advisers
New York
– – -250 Closed
BTI
5
Blue Trust Inc
Georgia
– – -65 Closed
MSCM
6
McElhenny Sheffield Capital Management
Texas
– – -31 Closed
IA
7
IFP Advisors
Florida
– – -1 Closed